Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

799 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Optical coherence tomography in secondary progressive multiple sclerosis: cross-sectional and longitudinal exploratory analysis from the MS-SMART randomised controlled trial.
De Angelis F, Cameron JR, Eshaghi A, Parker R, Connick P, Stutters J, Plantone D, Doshi A, John N, Williams T, Calvi A, MacManus D, Barkhof F, Chandran S, Weir CJ, Toosy A, Chataway J; MS-SMART trial investigators. De Angelis F, et al. J Neurol Neurosurg Psychiatry. 2024 Dec 18:jnnp-2024-334801. doi: 10.1136/jnnp-2024-334801. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39694820
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis.
John NA, Li Y, De Angelis F, Stutters J, Prados F, Doshi A, Calvi A, Williams T, Plantone D, Phan T, Gandini Wheeler-Kingshott CAM, Barkhof F, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: de angelis f. Eur J Neurol. 2025 Jan;32(1):e16586. doi: 10.1111/ene.16586. Eur J Neurol. 2025. PMID: 39691073 Free PMC article. Clinical Trial.
Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis.
Mongay-Ochoa N, Pareto D, Alberich M, Carbonell-Mirabent P, Valsasina P, Margoni M, Braga N, Vidal-Jordana A, Auger C, Tintore M, Meani A, Gobbi C, Zecca C, Barkhof F, Schoonheim MM, Strijbis EMM, Gallo A, Bisecco A, Ciccarelli O, De Angelis F, Yiannakas MC, Palace J, Matthews L, Gass A, Eisele P, Lukas C, Bellenberg B, Preziosa P, Montalban X, Rocca MA, Filippi M, Rovira À, Sastre-Garriga J; MAGNIMS study group (Magnetic Resonance Imaging in Multiple Sclerosis). Mongay-Ochoa N, et al. Among authors: de angelis f. Neurology. 2025 Jan 14;104(1):e210136. doi: 10.1212/WNL.0000000000210136. Epub 2024 Dec 12. Neurology. 2025. PMID: 39666921
Bariatric surgery does not affect kidney stone disease.
Iossa A, Pastore AL, Coluzzi I, Valenzi FM, De Angelis F, Bellini D, Lelli G, Cavallaro G. Iossa A, et al. Among authors: de angelis f. Sci Rep. 2024 Dec 4;14(1):30193. doi: 10.1038/s41598-024-78771-y. Sci Rep. 2024. PMID: 39632988 Free PMC article.
Solid-State Nanopores for Spatially Resolved Chemical Neuromodulation.
Vacca F, Galluzzi F, Blanco-Formoso M, Gianiorio T, De Fazio AF, Tantussi F, Stürmer S, Haq W, Zrenner E, Chaffiol A, Joffrois C, Picaud S, Benfenati F, De Angelis F, Colombo E. Vacca F, et al. Among authors: de angelis f. Nano Lett. 2024 Dec 4;24(48):15215-15225. doi: 10.1021/acs.nanolett.4c02604. Epub 2024 Nov 19. Nano Lett. 2024. PMID: 39561980 Free PMC article.
Le Pause Attive per la promozione dell’attività motoria: adesione degli istituti scolastici nel Lazio.
Culasso M, Biscaglia L, Barca A, Cairella G, Iacovacci S, Livrieri S, Porta D, Saulle R, Brandimarte MA, Casagni L, Coia M, Corradi S, De Angelis F, De Sbrocchi C, Di Cesare F, Fabrizi E, Ferri M, Grandi M, Guida S, Luzza M, Maciocia L, Mascagna F, Michienzi F, Quartieri C, Rossetti L, Spaziani G, Vincenzo Spina ML, Tavani S, Vallone A. Culasso M, et al. Among authors: de angelis f. Recenti Prog Med. 2024 Nov;115(11):545-546. doi: 10.1701/4365.43595. Recenti Prog Med. 2024. PMID: 39550656 Italian.
MEA-NAP: A flexible network analysis pipeline for neuronal 2D and 3D organoid multielectrode recordings.
Sit TPH, Feord RC, Dunn AWE, Chabros J, Oluigbo D, Smith HH, Burn L, Chang E, Boschi A, Yuan Y, Gibbons GM, Khayat-Khoei M, De Angelis F, Hemberg E, Hemberg M, Lancaster MA, Lakatos A, Eglen SJ, Paulsen O, Mierau SB. Sit TPH, et al. Among authors: de angelis f. Cell Rep Methods. 2024 Nov 18;4(11):100901. doi: 10.1016/j.crmeth.2024.100901. Epub 2024 Nov 8. Cell Rep Methods. 2024. PMID: 39520988 Free article.
Pembrolizumab With or Without Maintenance Olaparib for Metastatic Squamous NSCLC That Responded to First-Line Pembrolizumab Plus Chemotherapy.
Hochmair M, Schenker M, Cobo Dols M, Kim TM, Ozyilkan O, Smagina M, Leonova V, Kato T, Fedenko A, De Angelis F, Rittmeyer A, Gray JE, Greystoke A, Aggarwal H, Huang Q, Zhao B, Lara-Guerra H, Nadal E. Hochmair M, et al. Among authors: de angelis f. J Thorac Oncol. 2024 Oct 28:S1556-0864(24)02420-1. doi: 10.1016/j.jtho.2024.10.012. Online ahead of print. J Thorac Oncol. 2024. PMID: 39477187 Free article.
799 results